Back
Nautilus Biotechnology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
NAUT
Nautilus Biotechnology, Inc.
Last Price:
$2.00
Seasonality Move:
-17.65%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAUT is experiencing slight buying pressure.
Nautilus Biotechnology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.9 | Buy |
| 20-day SMA: | 2.01 | Sell |
| 50-day SMA: | 1.75 | Buy |
| 200-day SMA: | 1.02 | Buy |
| 8-day EMA: | 1.94 | Buy |
| 20-day EMA: | 1.94 | Buy |
| 50-day EMA: | 1.66 | Buy |
| 200-day EMA: | 0.75 | Buy |
Nautilus Biotechnology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 52.23 | Buy |
| Chaikin Money Flow: | 14842 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.91 - 2.19) | Sell |
| Bollinger Bands (100): | (0.68 - 1.82) | Buy |
Nautilus Biotechnology, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nautilus Biotechnology, Inc. Stock
Is Nautilus Biotechnology, Inc. Stock a Buy?
-
Nautilus Biotechnology, Inc. share price is 1.95 while NAUT 8-day simple moving average is 1.90, which is a Buy signal.
-
The stock price of NAUT is 1.95 while Nautilus Biotechnology, Inc. 20-day SMA is 2.01, which makes it a Sell.
-
Nautilus Biotechnology, Inc. 50-day simple moving average is 1.75 while NAUT share price is 1.95, making it a Buy technically.
-
NAUT stock price is 1.95 and Nautilus Biotechnology, Inc. 200-day simple moving average is 1.02, creating a Buy signal.
NAUT Technical Analysis vs Fundamental Analysis
Sell
34
Nautilus Biotechnology, Inc. (NAUT)
is a Sell
Is Nautilus Biotechnology, Inc. a Buy or a Sell?
-
Nautilus Biotechnology, Inc. stock is rated a SellThe current Nautilus Biotechnology, Inc. [NAUT] share price is $1.95. The Score for NAUT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Nautilus Biotechnology, Inc. Stock Info
Market Cap:
246.3M
Price in USD:
1.95
Share Volume:
103.9K
Nautilus Biotechnology, Inc. 52-Week Range
52-Week High:
2.54
52-Week Low:
0.62
Sell
34
Nautilus Biotechnology, Inc. (NAUT)
is a Sell
Nautilus Biotechnology, Inc. Share Price Forecast
-
What is the Nautilus Biotechnology, Inc. stock price today?The Nautilus Biotechnology, Inc. stock price is 1.95 USD today.
-
Will NAUT stock go up or go down?Nautilus Biotechnology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Nautilus Biotechnology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nautilus Biotechnology, Inc. is overvalued.
Is Nautilus Biotechnology, Inc. Stock a Buy?
-
Nautilus Biotechnology, Inc. share price is 1.95 while NAUT 8-day exponential moving average is 1.94, which is a Buy signal.
-
The stock price of NAUT is 1.95 while Nautilus Biotechnology, Inc. 20-day EMA is 1.94, which makes it a Buy.
-
Nautilus Biotechnology, Inc. 50-day exponential moving average is 1.66 while NAUT share price is 1.95, making it a Buy technically.
-
NAUT stock price is 1.95 and Nautilus Biotechnology, Inc. 200-day simple moving average is 0.75, creating a Buy signal.
Fundamental Analysis of Nautilus Biotechnology, Inc.
Is Nautilus Biotechnology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Nautilus Biotechnology, Inc.
Should I short Nautilus Biotechnology, Inc. stock?
-
NAUT Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Nautilus Biotechnology, Inc. is a Buy
-
Nautilus Biotechnology, Inc. Relative Strength Index (RSI) is 52.23, which suggest Nautilus Biotechnology, Inc. is overbought
-
The Bollinger Bands (25) for Nautilus Biotechnology, Inc. is (1.91 - 2.19), which suggest Nautilus Biotechnology, Inc. is a Buy
-
The Bollinger Bands (100) for Nautilus Biotechnology, Inc. is (0.68 - 1.82), which suggest Nautilus Biotechnology, Inc. is a Buy
* Nautilus Biotechnology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.